IFNA1 and COVID-19: As for most preexisting medical conditions, including cardiovascular diseases, hypertension, obesity, and diabetes mellitus, which increase the risk of severe COVID-19 [61,63], many studies have unraveled the progressive incidence of IFN insensitivity and chronic inflammation and have been reviewed elsewhere [40,41,42,69,70,71].